Since the advent of organ-on-a-chip, many researchers have tried to mimic the physiology of human tissue on an engineered platform. In the case of brain tissue, structural connections and cell鈥揷ell interactions are important factors for brain function. A brain-on-chip could be used to test the potential neurotoxicity of new drugs and to study the biochemical mechanisms underlying neurological disorders.
Highlights
The global Brain-on-chip Model market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Brain-on-chip Model is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Brain-on-chip Model is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Brain-on-chip Model in Pharmaceutical & Biotechnology Companies is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Brain-on-chip Model include Emulate, Kirkstall, CN Bio Innovations, Tissuse, Nortis, Hesperos, Else Else Kooi Laboratory, Mimetas and Draper Laboratory, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Brain-on-chip Model, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Brain-on-chip Model.
The Brain-on-chip Model market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Brain-on-chip Model market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Brain-on-chip Model companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Emulate
Kirkstall
CN Bio Innovations
Tissuse
Nortis
Hesperos
Else Else Kooi Laboratory
Mimetas
Draper Laboratory
Cherry Biotech SAS
Segment by Type
Therapeutic
Enhanced
Segment by Application
Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
Other End Users
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Brain-on-chip Model companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Brain-on-chip Model 麻豆原创 Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Therapeutic
1.2.3 Enhanced
1.3 麻豆原创 by Application
1.3.1 Global Brain-on-chip Model 麻豆原创 Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Pharmaceutical & Biotechnology Companies
1.3.3 Academic & Research Institutes
1.3.4 Other End Users
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Brain-on-chip Model 麻豆原创 Perspective (2018-2029)
2.2 Brain-on-chip Model Growth Trends by Region
2.2.1 Global Brain-on-chip Model 麻豆原创 Size by Region: 2018 VS 2022 VS 2029
2.2.2 Brain-on-chip Model Historic 麻豆原创 Size by Region (2018-2023)
2.2.3 Brain-on-chip Model Forecasted 麻豆原创 Size by Region (2024-2029)
2.3 Brain-on-chip Model 麻豆原创 Dynamics
2.3.1 Brain-on-chip Model Industry Trends
2.3.2 Brain-on-chip Model 麻豆原创 Drivers
2.3.3 Brain-on-chip Model 麻豆原创 Challenges
2.3.4 Brain-on-chip Model 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Brain-on-chip Model Players by Revenue
3.1.1 Global Top Brain-on-chip Model Players by Revenue (2018-2023)
3.1.2 Global Brain-on-chip Model Revenue 麻豆原创 Share by Players (2018-2023)
3.2 Global Brain-on-chip Model 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Brain-on-chip Model Revenue
3.4 Global Brain-on-chip Model 麻豆原创 Concentration Ratio
3.4.1 Global Brain-on-chip Model 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Brain-on-chip Model Revenue in 2022
3.5 Brain-on-chip Model Key Players Head office and Area Served
3.6 Key Players Brain-on-chip Model Product Solution and Service
3.7 Date of Enter into Brain-on-chip Model 麻豆原创
3.8 Mergers & Acquisitions, Expansion Plans
4 Brain-on-chip Model Breakdown Data by Type
4.1 Global Brain-on-chip Model Historic 麻豆原创 Size by Type (2018-2023)
4.2 Global Brain-on-chip Model Forecasted 麻豆原创 Size by Type (2024-2029)
5 Brain-on-chip Model Breakdown Data by Application
5.1 Global Brain-on-chip Model Historic 麻豆原创 Size by Application (2018-2023)
5.2 Global Brain-on-chip Model Forecasted 麻豆原创 Size by Application (2024-2029)
6 North America
6.1 North America Brain-on-chip Model 麻豆原创 Size (2018-2029)
6.2 North America Brain-on-chip Model 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Brain-on-chip Model 麻豆原创 Size by Country (2018-2023)
6.4 North America Brain-on-chip Model 麻豆原创 Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Brain-on-chip Model 麻豆原创 Size (2018-2029)
7.2 Europe Brain-on-chip Model 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Brain-on-chip Model 麻豆原创 Size by Country (2018-2023)
7.4 Europe Brain-on-chip Model 麻豆原创 Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Brain-on-chip Model 麻豆原创 Size (2018-2029)
8.2 Asia-Pacific Brain-on-chip Model 麻豆原创 Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Brain-on-chip Model 麻豆原创 Size by Region (2018-2023)
8.4 Asia-Pacific Brain-on-chip Model 麻豆原创 Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Brain-on-chip Model 麻豆原创 Size (2018-2029)
9.2 Latin America Brain-on-chip Model 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Brain-on-chip Model 麻豆原创 Size by Country (2018-2023)
9.4 Latin America Brain-on-chip Model 麻豆原创 Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Brain-on-chip Model 麻豆原创 Size (2018-2029)
10.2 Middle East & Africa Brain-on-chip Model 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Brain-on-chip Model 麻豆原创 Size by Country (2018-2023)
10.4 Middle East & Africa Brain-on-chip Model 麻豆原创 Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Emulate
11.1.1 Emulate Company Detail
11.1.2 Emulate Business Overview
11.1.3 Emulate Brain-on-chip Model Introduction
11.1.4 Emulate Revenue in Brain-on-chip Model Business (2018-2023)
11.1.5 Emulate Recent Development
11.2 Kirkstall
11.2.1 Kirkstall Company Detail
11.2.2 Kirkstall Business Overview
11.2.3 Kirkstall Brain-on-chip Model Introduction
11.2.4 Kirkstall Revenue in Brain-on-chip Model Business (2018-2023)
11.2.5 Kirkstall Recent Development
11.3 CN Bio Innovations
11.3.1 CN Bio Innovations Company Detail
11.3.2 CN Bio Innovations Business Overview
11.3.3 CN Bio Innovations Brain-on-chip Model Introduction
11.3.4 CN Bio Innovations Revenue in Brain-on-chip Model Business (2018-2023)
11.3.5 CN Bio Innovations Recent Development
11.4 Tissuse
11.4.1 Tissuse Company Detail
11.4.2 Tissuse Business Overview
11.4.3 Tissuse Brain-on-chip Model Introduction
11.4.4 Tissuse Revenue in Brain-on-chip Model Business (2018-2023)
11.4.5 Tissuse Recent Development
11.5 Nortis
11.5.1 Nortis Company Detail
11.5.2 Nortis Business Overview
11.5.3 Nortis Brain-on-chip Model Introduction
11.5.4 Nortis Revenue in Brain-on-chip Model Business (2018-2023)
11.5.5 Nortis Recent Development
11.6 Hesperos
11.6.1 Hesperos Company Detail
11.6.2 Hesperos Business Overview
11.6.3 Hesperos Brain-on-chip Model Introduction
11.6.4 Hesperos Revenue in Brain-on-chip Model Business (2018-2023)
11.6.5 Hesperos Recent Development
11.7 Else Else Kooi Laboratory
11.7.1 Else Else Kooi Laboratory Company Detail
11.7.2 Else Else Kooi Laboratory Business Overview
11.7.3 Else Else Kooi Laboratory Brain-on-chip Model Introduction
11.7.4 Else Else Kooi Laboratory Revenue in Brain-on-chip Model Business (2018-2023)
11.7.5 Else Else Kooi Laboratory Recent Development
11.8 Mimetas
11.8.1 Mimetas Company Detail
11.8.2 Mimetas Business Overview
11.8.3 Mimetas Brain-on-chip Model Introduction
11.8.4 Mimetas Revenue in Brain-on-chip Model Business (2018-2023)
11.8.5 Mimetas Recent Development
11.9 Draper Laboratory
11.9.1 Draper Laboratory Company Detail
11.9.2 Draper Laboratory Business Overview
11.9.3 Draper Laboratory Brain-on-chip Model Introduction
11.9.4 Draper Laboratory Revenue in Brain-on-chip Model Business (2018-2023)
11.9.5 Draper Laboratory Recent Development
11.10 Cherry Biotech SAS
11.10.1 Cherry Biotech SAS Company Detail
11.10.2 Cherry Biotech SAS Business Overview
11.10.3 Cherry Biotech SAS Brain-on-chip Model Introduction
11.10.4 Cherry Biotech SAS Revenue in Brain-on-chip Model Business (2018-2023)
11.10.5 Cherry Biotech SAS Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Emulate
Kirkstall
CN Bio Innovations
Tissuse
Nortis
Hesperos
Else Else Kooi Laboratory
Mimetas
Draper Laboratory
Cherry Biotech SAS
听
听
*If Applicable.
